Literature DB >> 2527270

Effect of membrane phospholipids on activation of the alternative complement pathway.

C Mold1.   

Abstract

Although some of the membrane glycoproteins that serve as activators or regulators of C activation have been identified, the influence of membrane lipids has not been studied extensively. A model of alternative C pathway activation was established using liposomes composed of cholesterol and synthetic phospholipids. Liposomes containing phosphatidylcholine (PC) as the sole phospholipid did not activate C as measured by C3 binding after incubation in normal human serum containing 2.5 mM MgCl2 and 10 mM EGTA. When phosphatidylethanolamine (PE) was included as 20% or more of the phospholipid, C3 binding was observed. C3 binding to liposomes was inhibited by salicylhydroxamic acid indicating binding through the C3 thioester bond. The phospholipid composition did not influence C3 binding to liposomes in an unregulated system of C3, B, D, and P indicating equivalent C3b binding sites on activating and nonactivating liposomes. When the regulatory proteins H and I were added to the other components, liposomes containing PE bound three times more C3 than PC liposomes suggesting that the phospholipid affects C3 regulation. This was tested directly in a radiolabeled H binding assay. In the presence of equal amounts of C3b, PC liposomes showed a greater number of high affinity H binding sites than PE liposomes. Using different PE derivatives, C activation could be directly related to the phospholipid polar head group. Liposomes containing PE, trinitrophenyl-PE or monomethyl-PE did activate the alternative C pathway, whereas those containing dimethyl-PE, PC, or phosphatidylserine did not. These studies provide evidence that primary and secondary amino groups on lipid membranes can decrease the interaction between H and C3b and provide sites for alternative pathway activation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527270

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Aspergillus fumigatus complement inhibitor: production, characterization, and purification by hydrophobic interaction and thin-layer chromatography.

Authors:  R G Washburn; D J DeHart; D E Agwu; B J Bryant-Varela; N C Julian
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Complementary recognition of alternative pathway activators by decay-accelerating factor and factor H.

Authors:  D Kraus; M E Medof; C Mold
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.

Authors:  M Susani; M Schulze; M Exner; D Kerjaschki
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

4.  Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.

Authors:  R H Wang; G Phillips; M E Medof; C Mold
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

5.  Skeletal muscle phosphatidylcholine and phosphatidylethanolamine are related to insulin sensitivity and respond to acute exercise in humans.

Authors:  Sean A Newsom; Joseph T Brozinick; Katja Kiseljak-Vassiliades; Allison N Strauss; Samantha D Bacon; Anna A Kerege; Hai Hoang Bui; Phil Sanders; Parker Siddall; Tao Wei; Melissa Thomas; Ming Shang Kuo; Travis Nemkov; Angelo D'Alessandro; Kirk C Hansen; Leigh Perreault; Bryan C Bergman
Journal:  J Appl Physiol (1985)       Date:  2016-03-31

6.  In Vivo Fluorescence Imaging of Passive Inflammation Site Accumulation of Liposomes via Intravenous Administration Focused on Their Surface Charge and PEG Modification.

Authors:  Hisako Ibaraki; Akihiro Takeda; Naoki Arima; Naruhiro Hatakeyama; Yuuki Takashima; Yasuo Seta; Takanori Kanazawa
Journal:  Pharmaceutics       Date:  2021-01-14       Impact factor: 6.321

7.  Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells.

Authors:  Weihan Yang; Yu Wang; Qiang Pu; Sujuan Ye; Qingping Ma; Jiang Ren; Guoxing Zhong; Lunxu Liu; Wen Zhu
Journal:  Mol Med Rep       Date:  2014-07-14       Impact factor: 2.952

8.  Skeletal muscle phosphatidylcholine and phosphatidylethanolamine respond to exercise and influence insulin sensitivity in men.

Authors:  Sindre Lee; Frode Norheim; Hanne L Gulseth; Torgrim M Langleite; Andreas Aker; Thomas E Gundersen; Torgeir Holen; Kåre I Birkeland; Christian A Drevon
Journal:  Sci Rep       Date:  2018-04-25       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.